Skip to content

Regular Sauna Use to Lower Blood Pressure in Primary Aldosteronism

Sauna as an Adjunct to Usual Medical Therapy for Non-reNAl Sodium Elimination in Primary Aldosteronism: Pilot Study (SAUNA-PA)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07796048
Acronym
SAUNA-PA
Enrollment
10
Registered
2026-08-31
Start date
2026-09-30
Completion date
2028-09-30
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Primary Aldosteronism

Keywords

sodium, salt, sauna, hypertension, aldosterone

Brief summary

1. Background and Rationale: Primary aldosteronism is a hypertension-related disorder where salt restriction/salt loss is a central part of therapy. Dietary salt restriction to sufficient degree is very difficult for most patients and thus medications are frequently required to control blood pressure. Non-pharmacologic means of reducing total body sodium and blood pressure are required and desired by patients. Sauna bathing is a traditional wellness practice associated with extensive sweating and therefore salt loss. We wish to study whether incorporation of sauna bathing into a treatment plan for primary aldosteronism might lower blood pressure without increased medications. A pilot feasibility study is required prior to design of a larger controlled clinical trial. We are looking to conduct a short term simulated sauna study to assess patient acceptability and study feasibility as the primary outcomes. 2. Research Questions and Objectives: This study will test the feasibility of having patients add regular sauna usage to their weekly lifestyle, while being treated for hypertension due to primary aldosteronism. The primary objective will be to assess patient recruitment rates, subject retention, patient acceptability, and patient adherence to regular sauna intervention during a 2-week period, using an a priori "traffic light" decision matrix. The secondary objectives will be to explore change in blood pressure, as measured by a wearable, continuous BP wrist monitor, before and after a 2 week sauna intervention. 3. Methods: The study will occur in the context of routine ongoing care in the Endocrine Hypertension Clinic. Ten patients with primary aldosteronism will be recruited to a 7 week study where we will observe the feasibility and acceptability of wearing a continuous, cuffless, wrist BP monitoring device for 2-week periods prior to, during, and after a 2 week "sauna" therapy program. The sauna therapy will consist of three 30 minute visits to a commercially licensed and insured local sauna club each week for 2 weeks. Standardized subject experience questionnaires will collect feasibility and acceptability data which will be analyzed with a standard red light/yellow light/green light approach to study feasibility conclusions.

Interventions

BEHAVIORALsauna session

thrice-weekly, 30-minute sauna session for 2 weeks

Sponsors

University of Calgary
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* a) Age 18-65 b) Hypertension with PA diagnosed using Endocrine Society's 2025 criteria c) Stable medical therapy with no change in dose/agent in prior 6 weeks d) BP uncontrolled, clinic \> 140/90 or ABPM mean \> 135/85 e) Dietary sodium moderate or higher (\> 128 mmol/d) f) Subject owns iPhone (12-16) or Android and willing to install HiLo app

Exclusion criteria

1. BP \> 160/105 in clinic or \> 155/100 on ABPM 2. Planning adrenalectomy or other surgery during trial 3. Recent hospitalization for any reason, in the past 3 months 4. Confirmed or suspected MI, angina, CHF or arrhythmia diagnosis in the past 6 months 5. CKD, eGFR \< 30 ml/min/m2 6. Pregnancy, planned pregnancy, or non-use of contraceptive during study 7. Recent hypotensive event/syncope in the past 3 months 8. Any complex medical condition where sauna exposure is not advised 9. Planning major dietary change 10. History of medication non-adherence 11. Night shift worker / at work after 2000h 12. Planned vacation/absence during 6-week study 13. Inability to read English or consent to participation

Design outcomes

Primary

MeasureTime frameDescription
approach-to-consent ratiofrom study initiation to end of recruitment window 52 weeks laterCalculated ratio of subjects approached for recruitment vs number agreed to participate
Mean monthly enrolment ratewithin 6 months of study initiationNumber of subjects enrolled per month from study opening
Drop out ratefrom subject enrolment to intervention completion 7 weeks later.Percentage of subjects who do not complete the 7 week sauna study after enrolment.
HILO BP monitor wearabilityFrom enrolment to intervention completion, 7 weeks.Number of hours of data recorded showing % of time the HILO monitor was worn during the 7 week study.
Score on the Acceptability of Intervention Measurefrom enrolment to study intervention completion, 7 weeks.Mean score (/20) on the patient-scoring system Acceptability of Intervention Measure
Sauna Usability2 weeks of sauna intervention phaseProportion of subjects attending 4 or more of the 6 scheduled sauna sessions

Secondary

MeasureTime frameDescription
24 hour mean blood pressure3 time frames: first two weeks of run-in, two weeks of intervention, two weeks of run-out.24 hour mean blood pressure from HILO monitoring data
Daytime mean blood pressure3 time frames: first two weeks of run-in, two weeks of intervention, two weeks of run-out.Daytime (0700-2300) mean BP from HILO monitor
Nighttime mean blood pressure3 time frames: first two weeks of run-in, two weeks of intervention, two weeks of run-out.Mean BP (2300-0700) from HILO BP monitor device

Contacts

CONTACTGregory Kline, MD
gakline@ucalgary.ca403-955-8327

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026